Literature DB >> 11240082

Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurones in a rat model of mononeuropathy.

R Suzuki1, E A Matthews, A H Dickenson.   

Abstract

Selective ligation of the L5/L6 spinal nerves produces a partial denervation of the hindpaw and has proved to be a useful model for studying the mechanisms underlying neuropathic pain. Two weeks after surgery, in vivo electrophysiological studies were performed in sham operated and nerve injured rats and the responses of spinal dorsal horn neurones to controlled electrical and natural (mechanical and heat) stimuli were recorded. The systemic effects of three N-methyl-D-aspartate receptor (NMDA) antagonists, ketamine (1-10 mg/kg), memantine (1-20 mg/kg) and MK-801 (0.1-5 mg/kg) were compared. Ketamine a clinically available NMDA receptor antagonist, produced greater reductions of the postdischarge, thermal (10 mg/kg, P=0.02), and mechanical evoked responses in spinal nerve ligated (SNL) rats (von Frey 9 g, 1 mg/kg, P=0.04; 5 mg/kg, P=0.01; 10 mg/kg, P=0.05; von Frey 50 g, 5 mg/kg, P=0.02; 10 mg/kg, P=0.003). The inhibition of wind-up was comparable in both animal groups. Memantine produced powerful inhibitions of wind-up after nerve injury with little effect in sham controls (5 mg/kg, P=0.02). The postdischarge, mechanical and thermal evoked responses were reduced to similar extents by memantine in both experimental groups. The effects of MK-801 were comparable between SNL and sham operated rats for all neuronal measures (wind-up, postdischarge, thermal and noxious mechanical evoked responses). The differential blocking abilities of these antagonists on the various neuronal responses may relate to the characteristics of their voltage-dependent blockage of the channel associated with the receptor. The favourable side effect profile of memantine supports its potential use for the treatment of neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11240082     DOI: 10.1016/s0304-3959(00)00423-1

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  25 in total

1.  The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury.

Authors:  R Suzuki; L C Stanfa; E A Kowaluk; M Williams; M F Jarvis; A H Dickenson
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 2.  Neuropharmacologic targets and agents in fibromyalgia.

Authors:  Rie Suzuki; Anthony H Dickenson
Journal:  Curr Pain Headache Rep       Date:  2002-08

3.  Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain.

Authors:  Shao-Rui Chen; Gary Samoriski; Hui-Lin Pan
Journal:  Neuropharmacology       Date:  2009-05-05       Impact factor: 5.250

4.  Inflammatory 'double hit' model of temporomandibular joint disorder with elevated CCL2, CXCL9, CXCL10, RANTES and behavioural hypersensitivity in TNFR1/R2-/- mice.

Authors:  S L McIlwrath; R Nesemeier; F Ma; H S Oz; L Zhang; K N Westlund
Journal:  Eur J Pain       Date:  2017-03-20       Impact factor: 3.931

5.  Cav1.2 and Cav1.3 L-type calcium channels independently control short- and long-term sensitization to pain.

Authors:  Houda Radwani; Maria José Lopez-Gonzalez; Daniel Cattaert; Olivier Roca-Lapirot; Eric Dobremez; Rabia Bouali-Benazzouz; Emelía Eiríksdóttir; Ülo Langel; Alexandre Favereaux; Mohammed Errami; Marc Landry; Pascal Fossat
Journal:  J Physiol       Date:  2016-07-03       Impact factor: 5.182

6.  Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors.

Authors:  Alexandra E Smith; Zhili Xu; Yvonne Y Lai; Pushkar M Kulkarni; Ganesh A Thakur; Andrea G Hohmann; Jonathon D Crystal
Journal:  Behav Brain Res       Date:  2016-02-22       Impact factor: 3.332

Review 7.  Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain.

Authors:  Hong-Yi Zhou; Shao-Rui Chen; Hui-Lin Pan
Journal:  Expert Rev Clin Pharmacol       Date:  2011-05       Impact factor: 5.045

Review 8.  Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

Authors:  Clare Finlay; Susan Duty
Journal:  J Neural Transm (Vienna)       Date:  2014-02-21       Impact factor: 3.575

9.  Role of Fyn-mediated NMDA receptor function in prediabetic neuropathy in mice.

Authors:  Meng Suo; Ping Wang; Mengyuan Zhang
Journal:  J Neurophysiol       Date:  2016-05-04       Impact factor: 2.714

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.